LIC MF Healthcare Fund Direct IDCW
Summary Info
Fund Name
: LIC Mutual Fund
Scheme Name
: LIC MF Healthcare Fund Direct IDCW
AMC
: LIC Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 08-Feb-2019
Fund Manager
: Karan Doshi
Net Assets (Rs. cr)
: 83.12
LIC MF Healthcare Fund Direct IDCW - Nav Details
Nav Date
: 11-Feb-2026
NAV [Rs.]
: 31.1014
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: 1.00% For exit within 12 months from the date of allotment. Nil - For exit after 12 months from the date of allotment.
LIC MF Healthcare Fund Direct IDCW- NAV Chart
LIC MF Healthcare Fund Direct IDCW- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 1.99 | -2.54 | -4.58 | -1.89 | 2.86 | 21.69 | 12.4 | 17.7 |
| Category Avg | 1.29 | -1.71 | -3.48 | -0.76 | 1.71 | 22.65 | 14.87 | 12.72 |
| Category Best | 2.54 | 0.68 | -0.75 | 2.64 | 8.62 | 27.68 | 17.6 | 27.42 |
| Category Worst | 0.33 | -5.59 | -7.47 | -5.27 | -6.89 | 17.93 | 10.94 | -6.79 |
LIC MF Healthcare Fund Direct IDCW- Latest Dividends
No Records Found
LIC MF Healthcare Fund Direct IDCW- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 500
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 10.64 | 52436 | 8.36 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 6.61 | 13130 | 5.20 |
| Equity | Apollo Hospitals | Healthcare Services | 5.95 | 6723 | 4.67 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.81 | 31301 | 3.78 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 4.74 | 6158 | 3.72 |
| Equity | Fortis Health. | Healthcare Services | 4.66 | 43032 | 3.66 |
| Equity | Neuland Labs. | Pharmaceuticals & Biotechnology | 4.36 | 2585 | 3.42 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 4.29 | 218361 | 3.37 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.62 | 5008 | 2.84 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 3.39 | 968 | 2.66 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 3.29 | 19567 | 2.59 |
| Equity | Navin Fluo.Intl. | Chemicals & Petrochemicals | 3.19 | 4116 | 2.51 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 3.13 | 13351 | 2.46 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 3.11 | 16604 | 2.44 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 3.07 | 11994 | 2.41 |
| Equity | Artemis Medicare | Healthcare Services | 2.95 | 93529 | 2.31 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 2.91 | 19474 | 2.28 |
| Equity | OneSource Speci. | Pharmaceuticals & Biotechnology | 2.83 | 18661 | 2.22 |
| Equity | Metropolis Healt | Healthcare Services | 2.72 | 11417 | 2.13 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.32 | 8577 | 1.82 |
| Equity | Dr Agarwal's Hea | Healthcare Services | 2.18 | 39576 | 1.71 |
| Equity | Max Healthcare | Healthcare Services | 2.04 | 16775 | 1.60 |
| Equity | Global Health | Healthcare Services | 2.00 | 14952 | 1.57 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 1.75 | 22961 | 1.37 |
| Equity | Syngene Intl. | Healthcare Services | 1.70 | 28260 | 1.33 |
| Equity | Vinati Organics | Chemicals & Petrochemicals | 1.70 | 8741 | 1.33 |
| Equity | Acutaas Chemical | Pharmaceuticals & Biotechnology | 1.53 | 6296 | 1.20 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
LIC Mutual Fund
Incorporation Date:
20-Apr-1994
Total Assets Managed (Cr.):
44,894.42
Trustee/s:
Mr. Pradeep Jagannath Bhi, LIC Mutual Fund Trustee P
Chairman:
NA
CEO / MD:
T.S. Ramakrishnan, Ravi Kumar Jha
CIO:
NA
President:
NA
Director/s:
Raghunandan Maluste, Vijay Sharma, Sanjay Achyutrao Muthal, Praveen Garg
Compliance Officer/s:
NA
Investor Service Officer/s:
Mr.Prashant Thakkar
Fund Manager/s:
Karan Doshi
Auditors:
S.R. Batliboi LLP
OTHER INFORMATION
Registered Office:
4th Floor, Industrial Insurance Building, Opp.Churchgate Stati Mumbai 400 020.
Contact Nos:
022-66016000
Fax:
022-22843660
Email:
Website:
